| pubmed-article:2138474 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2138474 | lifeskim:mentions | umls-concept:C0006826 | lld:lifeskim |
| pubmed-article:2138474 | lifeskim:mentions | umls-concept:C0085979 | lld:lifeskim |
| pubmed-article:2138474 | lifeskim:mentions | umls-concept:C0023779 | lld:lifeskim |
| pubmed-article:2138474 | lifeskim:mentions | umls-concept:C0024485 | lld:lifeskim |
| pubmed-article:2138474 | lifeskim:mentions | umls-concept:C0033727 | lld:lifeskim |
| pubmed-article:2138474 | lifeskim:mentions | umls-concept:C1515926 | lld:lifeskim |
| pubmed-article:2138474 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:2138474 | pubmed:dateCreated | 1990-5-7 | lld:pubmed |
| pubmed-article:2138474 | pubmed:abstractText | Water-suppressed proton nuclear magnetic resonance spectroscopy was used to observe plasma lipoprotein lipid methyl and methylene resonances from guinea pigs which had been injected with viable or heat-killed line 1 or line 10 tumor cells or sterile oil. It was shown that the widths of these resonances became significantly sharper as the number of tumor cells grew. Plasma from tumor-free control animals showed no change in the NMR linewidths. It is concluded that the changes observed reflect a specific host response to viable tumor cells, and in these models there is a reciprocal relationship between the number of viable tumor cells and the linewidths of plasma lipoprotein methyl and methylene resonances. | lld:pubmed |
| pubmed-article:2138474 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2138474 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2138474 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2138474 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2138474 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2138474 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2138474 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:2138474 | pubmed:issn | 0959-8049 | lld:pubmed |
| pubmed-article:2138474 | pubmed:author | pubmed-author:DvorakH FHF | lld:pubmed |
| pubmed-article:2138474 | pubmed:author | pubmed-author:FosselE TET | lld:pubmed |
| pubmed-article:2138474 | pubmed:author | pubmed-author:McDonaghJJ | lld:pubmed |
| pubmed-article:2138474 | pubmed:author | pubmed-author:CaroJ HJH | lld:pubmed |
| pubmed-article:2138474 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2138474 | pubmed:volume | 26 | lld:pubmed |
| pubmed-article:2138474 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2138474 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2138474 | pubmed:pagination | 29-32 | lld:pubmed |
| pubmed-article:2138474 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:2138474 | pubmed:meshHeading | pubmed-meshheading:2138474-... | lld:pubmed |
| pubmed-article:2138474 | pubmed:meshHeading | pubmed-meshheading:2138474-... | lld:pubmed |
| pubmed-article:2138474 | pubmed:meshHeading | pubmed-meshheading:2138474-... | lld:pubmed |
| pubmed-article:2138474 | pubmed:meshHeading | pubmed-meshheading:2138474-... | lld:pubmed |
| pubmed-article:2138474 | pubmed:meshHeading | pubmed-meshheading:2138474-... | lld:pubmed |
| pubmed-article:2138474 | pubmed:year | 1990 | lld:pubmed |
| pubmed-article:2138474 | pubmed:articleTitle | Alteration of aliphatic lipid proton NMR linewidths by malignant tumors in guinea pigs. | lld:pubmed |
| pubmed-article:2138474 | pubmed:affiliation | Department of Radiology, Charles A. Dana Research Institute, Beth Israel Hospital, Boston, MA 02215. | lld:pubmed |
| pubmed-article:2138474 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2138474 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
